Archives - Nov. 5, 2008

A European and American study on a new synthetic drug found that it protected laboratory mice from diet-induced obesity and its potential consequences like glucose intolerance and insensitivity to insulin by activating an enzyme that promoted fat consumption and exercise endurance, leading to suggestions that it could be an important new weapon in the fight against obesity and diabetes.

A study conducted by Kaiser Permanente Southern California has shown that proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk. The study was published online on November 3 by The Journal of Bone & Joint Surgery, a peer-reviewed journal. The five-year study led by Richard M.

Pycnodysostosis, a condition from which the painter Henri de Toulouse-Lautrec suffered, is a genetic disease characterized by short stature. This rare disease, surprisingly, provides a window into how joints are destroyed by arthritis. It is caused by deficiency of an enzyme known as cathepsin K which hampers osteoclasts (the cells that break down bone in bone modeling and repair), leading to poor bone resorption and dense, brittle bones.

Rush University Medical Center study finds more complications in men over the age of 55 and women Hip resurfacing is often seen as a modern alternative to the more conventional total hip replacement, but new data from a study led by Rush University Medical Center in Chicago, USA, suggest that a patient's age and gender are key to the operation's success. The study will be published in the December issue of the Springer journal Clinical Orthopaedics and Related Research.

Proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk, according to a study conducted by Kaiser Permanente Southern California. The study was published online on November 3 by The Journal of Bone & Joint Surgery, a peer-reviewed journal.